Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 10.2B | 8.7B | 7.9B | 9.1B |
Cost of revenue | 10.3B | 5.4B | 5.5B | 6.5B |
Gross profit | -77.2M | 3.2B | 2.4B | 2.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | -2.1B | 1.4B | 942.8M | 718.8M |
Operating income | 1.4B | 1.1B | 864.6M | 1.3B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 435.8M | 499.3M | 342.8M | 301.1M |
Other income expense | — | — | — | — |
Pretax income | 1.5B | 1.2B | 1.0B | 1.5B |
Tax provision | 366.7M | 335.9M | 283.7M | 377.9M |
Net income | 1.1B | 770.5M | 615.6M | 1.1B |
Basic EPS | — | 5.2 | 4.3 | 7.2 |
Diluted EPS | — | 5.2 | 4.2 | 7.1 |
Basic average shares | — | 137.2M | 136.4M | 136.5M |
Diluted average shares | — | 138.5M | 138.3M | 138.4M |
EBITDA | 2.1B | 1.8B | 1.5B | 1.9B |
Net income from continuing op. | — | — | — | — |
Minority interests | -109.5M | -55.6M | -30.5M | -117.1M |
Preferred stock dividends | 0 | 0 | 0 | 0 |